Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

When the lines of cars begin to form outside St. John the Baptist Roman Catholic Church in Rome, New York — one of four churches under the newly-minted Sacred Heart Parish umbrella — on the second ...

Eleanor has an undergraduate degree in zoology from the University of Reading and a master’s in wildlife documentary production from the University of Salford. Eleanor has an undergraduate degree in ...

TOSHI price has surged over 84% after listings on Upbit and Binance Futures. Key support sits near $0.00062689 at the 61.8% Fibonacci retracement. Exchange outflows and altcoin momentum are fueling ...

Bitcoin’s recent price moves have closely followed a two-year Fibonacci model. According to analyst CryptoCon, the next logical level could be around $166,000. Bitcoin’s (BTC) recent all-time high ...